16227145

Source:http://linkedlifedata.com/resource/pubmed/id/16227145

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0018801, umls-concept:C0035171, umls-concept:C0087111, umls-concept:C0360714, umls-concept:C0965129, umls-concept:C1442488, umls-concept:C1521970, umls-concept:C2587213, umls-concept:C2603343
pubmed:issue	6
pubmed:dateCreated	2005-10-17
pubmed:abstractText	Previous prospective outcome studies of statins have not provided any guidance on benefit-risk in patients with heart failure.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100887595
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Fluorobenzenes, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides, http://linkedlifedata.com/resource/pubmed/chemical/rosuvastatin
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1388-9842
pubmed:author	pubmed-author:BlideskogMalinM, pubmed-author:CORONA Study Group, pubmed-author:DunselmanPeterP, pubmed-author:EskilsonChristinaC, pubmed-author:HjalmarsonAkeA, pubmed-author:KjekshusJohnJ, pubmed-author:McMurrayJohn VJV, pubmed-author:WaagsteinFinnF, pubmed-author:WedelHansH, pubmed-author:WessmanPeterP, pubmed-author:WikstrandJohnJ
pubmed:issnType	Print
pubmed:volume	7
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1059-69
pubmed:dateRevised	2011-6-8
pubmed:meshHeading	pubmed-meshheading:16227145-Age Factors, pubmed-meshheading:16227145-Aged, pubmed-meshheading:16227145-Dose-Response Relationship, Drug, pubmed-meshheading:16227145-Double-Blind Method, pubmed-meshheading:16227145-Drug Administration Schedule, pubmed-meshheading:16227145-Female, pubmed-meshheading:16227145-Fluorobenzenes, pubmed-meshheading:16227145-Follow-Up Studies, pubmed-meshheading:16227145-Heart Failure, pubmed-meshheading:16227145-Humans, pubmed-meshheading:16227145-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:16227145-Hypercholesterolemia, pubmed-meshheading:16227145-International Cooperation, pubmed-meshheading:16227145-Male, pubmed-meshheading:16227145-Middle Aged, pubmed-meshheading:16227145-Probability, pubmed-meshheading:16227145-Prospective Studies, pubmed-meshheading:16227145-Pyrimidines, pubmed-meshheading:16227145-Risk Assessment, pubmed-meshheading:16227145-Severity of Illness Index, pubmed-meshheading:16227145-Sulfonamides, pubmed-meshheading:16227145-Survival Analysis, pubmed-meshheading:16227145-Treatment Outcome
pubmed:year	2005
pubmed:articleTitle	A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics.
pubmed:affiliation	Department of Cardiology, Rikshospitalet University Hospital, University of Oslo, Sognsvannsveien 20, Oslo 0027, Norway.
pubmed:publicationType	Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study